- Home
- VKTX vs HASI Comparison
VKTX vs HASI Comparison
Compare VKTX & HASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VKTX
- HASI
- Stock Information
- Founded
- VKTX 2012
- HASI 1981
- Country
- VKTX United States
- HASI United States
- Employees
- VKTX N/A
- HASI N/A
- Industry
- VKTX Biotechnology: Pharmaceutical Preparations
- HASI Real Estate Investment Trusts
- Sector
- VKTX Health Care
- HASI Real Estate
- Exchange
- VKTX Nasdaq
- HASI Nasdaq
- Market Cap
- VKTX 3.8B
- HASI 3.6B
- IPO Year
- VKTX 2015
- HASI 2013
- Fundamental
- Price
- VKTX $38.17
- HASI $27.73
- Analyst Decision
- VKTX Strong Buy
- HASI Strong Buy
- Analyst Count
- VKTX 14
- HASI 6
- Target Price
- VKTX $87.00
- HASI $38.67
- AVG Volume (30 Days)
- VKTX 5.0M
- HASI 1.2M
- Earning Date
- VKTX 10-22-2025
- HASI 11-06-2025
- Dividend Yield
- VKTX N/A
- HASI 6.06%
- EPS Growth
- VKTX N/A
- HASI N/A
- EPS
- VKTX N/A
- HASI 1.59
- Revenue
- VKTX N/A
- HASI $92,418,000.00
- Revenue This Year
- VKTX N/A
- HASI $184.74
- Revenue Next Year
- VKTX N/A
- HASI $13.79
- P/E Ratio
- VKTX N/A
- HASI $17.46
- Revenue Growth
- VKTX N/A
- HASI N/A
- 52 Week Low
- VKTX $18.92
- HASI $21.98
- 52 Week High
- VKTX $79.10
- HASI $36.56
- Technical
- Relative Strength Index (RSI)
- VKTX 66.94
- HASI 38.24
- Support Level
- VKTX $33.00
- HASI $27.72
- Resistance Level
- VKTX $36.11
- HASI $29.10
- Average True Range (ATR)
- VKTX 2.05
- HASI 0.80
- MACD
- VKTX 0.25
- HASI -0.24
- Stochastic Oscillator
- VKTX 83.94
- HASI 8.93
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
About HASI Hannon Armstrong Sustainable Infrastructure Capital Inc.
HA Sustainable Infrastructure Capital Inc is an investor in sustainable infrastructure assets advancing the energy transition. Its investment is focused on actively partnering with clients to deploy capital in income-generating real assets that are supported by long-term recurring cash flows. This enabled to the generation of attractive risk-adjusted returns and provided stockholders with diversified exposure to the energy transition.